Showing results (31-40 of 610) with videos related to
Sort By:
Pageof 61
Therapeutic Advances in Medical Oncology|August 13, 2020
Molecular subtypes and the evolution of treatment management in metastatic colorectal cancerGiulia Martini, Rodrigo Dienstmann, Javier Ros, et al.Clinical Breast Cancer|November 10, 2006
Evidence-based neoadjuvant endocrine therapy for breast cancerRodrigo Dienstmann, Jose BinesExpert Opinion on Biological Therapy|June 18, 2011
Necitumumab in the treatment of advanced non-small cell lung cancer: translation from preclinical to clinical developmentRodrigo Dienstmann, Enriqueta FelipESMO Open|November 15, 2018
Precision oncology: separating the wheat from the chaffJordi Remon, Rodrigo DienstmannCurrent Clinical Pharmacology|April 22, 2010
Monoclonal antibodies in solid tumoursBen Markman, Josep TaberneroCancer Cell|December 15, 2020
The Effective Targeting of KRASG12C ElusivenessElena Elez, Josep TaberneroCancer Discovery|July 8, 2017
Improving the Armamentarium of PI3K Inhibitors with Isoform-Selective Agents: A New Light in the DarknessJordi Rodon, Josep TaberneroCancer Discovery|May 16, 2012
A shining light in the darkness for the treatment of pancreatic neuroendocrine tumorsJaume Capdevila, Josep TaberneroCancer Discovery|March 5, 2013
Molecular dissection of microsatellite instable colorectal cancerEduardo Vilar, Josep TaberneroClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
New approaches but the same flaws in the search for prognostic signaturesRamon Salazar, Josep TaberneroPageof 61